Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2023-07-20 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2023-07-20 English
In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 38th Annual General Meeting ....
Regulatory Filings
2023-07-20 English
Please find enclosed herewith proceedings of the 38th Annual General Meeting held on Wednesday, July 19, 2023 at 11:00 a.m. through Video Conferencing ("VC")/Other Audio-Visual Means ("OVAM").
AGM Information Classification · 100% confidence The document is a detailed record of the proceedings of the 38th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on July 19, 2023. It includes information about the meeting's conduct, attendees, agenda items, speeches by the Chairman and Managing Director, and voting procedures. The document references the AGM explicitly multiple times and contains no financial statements or detailed financial analysis itself, but rather the minutes and proceedings of the AGM. It is not an announcement of the AGM or voting results but the actual proceedings document. Therefore, it fits the category of AGM Information (AGM-R).
2023-07-19 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed disclosure of the proceedings of the 38th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on July 19, 2023. It includes information about the meeting's conduct, attendees, agenda items, speeches by the Chairman and Managing Director, and voting procedures. The document references compliance with SEBI and MCA regulations related to AGMs and mentions the adoption of financial statements and dividend declarations as part of the meeting. It does not contain the full annual report or financial statements themselves but rather the minutes and proceedings of the AGM. Therefore, this document fits the category of AGM Information (AGM-R). The document length (9120 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive record of the AGM proceedings.
2023-07-19 English
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication addressed to stock exchanges (Stock Exchange of India and BSE Limited) reporting the outcome of the 38th Annual General Meeting (AGM) held on July 19, 2023. It details the business transacted at the AGM, including adoption of audited financial statements, declaration of dividend, re-appointment of a director, and approval of related party transactions. The document is an announcement of the AGM results rather than the full AGM materials or presentations. It is relatively short (3503 characters) and serves as an official notification of voting outcomes and resolutions passed at the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-07-19 English
Please find enclosed herewith Outcome of 38th Annual General Meeting ("AGM") of the Company held today i.e. Wednesday, July 19, 2023.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) reporting the outcome of the company's 38th Annual General Meeting (AGM) held on July 19, 2023. It details the resolutions passed, including adoption of audited financial statements, declaration of dividend, re-appointment of a director, and approval of related party transactions. The document does not contain the full AGM presentation materials but rather the official results and decisions made at the AGM. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length is 3369 characters, which is consistent with a voting results announcement rather than a full AGM presentation or annual report. Therefore, the correct classification is DVA.
2023-07-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.